Why EyeWise Diagnostics?
EyeWise Diagnostics has the technology to early detect and track:
Alzheimer Disease (AD) – 10 to 20 years before symptoms are noticeable!
Age-related Macular Degeneration (AMD)
Computer Vision Syndrome (CVS)
EyeWise device uses a standard non-invasive eye examination.
The EyeWise device will be available soon to all optometrist, ophthalmologist and hospital clinics at an affordable price.
We use Artificial Intelligence and Machine Learning algorithms to continuously improve our diagnosis and patient tracking process as they change their life style or receive medical treatment.
Optometrists, optical stores will use the EyeWise technology and device to give more accurate eye examination that will test both eye tracking simultaneously.
Our Technology is currently registered as a Pending Patent in the US and in Israel.
Special Partnership Program
We offer a special Partnership Program for:
Optical store and chain managers
Private equity investors
Distributors of optical equipment and service professionals
AI and ML experts
PRESIDENT & FOUNDER - Expert optometrist with over 40 years of experience
CEO - Entrepreneur, AI. Analytics & Innovation MBA, Bsc Electrical Eng. Technion. Development mgr @ Intel
Dr. Valery Diatchuk
CLINICAL DEVELOPMENT - Expert ophthalmologist and eye surgeon
Dr. Noam Livneh
IMAGE PROCESSING - CTO of NeviMed. Over 30 years of expertise image processing and a vast experience in system architecture
Dr. Ehud Reich
BUSINESS DEVELOPMENT - Consultant Ocular Oncology & Oculoplastic Surgeon, Davidoff Oncology Center & Department of Ophthalmology
Prof. Yitzhak Hemo
ADVISORY BOARD MEMBER - Head of the Vitro-Retinal service Department of Opthalmology at Hadassah University Hospital